Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1872]
News [4281]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
Issues with reliability in HER2 testing and avastin for metastatic breast cancer
Dr Edith Perez – Mayo Clinic, Florida, USA
Issues with reliability in HER2 testing and avastin for metastatic breast cancer ( Dr Edith Perez – Mayo Clinic, Florida, USA )
19 Jan 2011
Targeting of breast cancer tumour initiating cells
Dr Jeffrey Rosen – Baylor College of Medicine, Houston, USA
Targeting of breast cancer tumour initiating cells ( Dr Jeffrey Rosen – Baylor College of Medicine, Houston, USA )
19 Jan 2011
Exemestane potential for hormone-receptor positive, early-stage breast cancer...
Dr Leif Ellisen - Massachusetts General Hospital, Boston, USA
Exemestane potential for hormone-receptor positive, early-stage breast cancer in the adjuvant setting ( Dr Leif Ellisen - Massachusetts General Hospital, Boston, USA )
19 Jan 2011
Pertuzumab and trastuzumab combination improved efficacy for women with HER2...
Prof Luca Gianni - Fondazione IRCCS Istituto Tumori di Milano, Italy
Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer ( Prof Luca Gianni - Fondazione IRCCS Istituto Tumori di Milano, Italy )
18 Jan 2011
Neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer
Prof Michael Untch - Helios Clinic, Berlin, Germany
Neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer ( Prof Michael Untch - Helios Clinic, Berlin, Germany )
18 Jan 2011
Combination therapy reduced HER2-positive breast cancers
Prof José Baselga - Massachusetts General Hospital Cancer Center, USA
Combination therapy reduced HER2-positive breast cancers ( Prof José Baselga - Massachusetts General Hospital Cancer Center, USA )
18 Jan 2011
CTCs predicted recurrence and death in patients with early-stage breast cancer
Dr Brigitte Rack - Munich University Hospital, Germany
CTCs predicted recurrence and death in patients with early-stage breast cancer ( Dr Brigitte Rack - Munich University Hospital, Germany )
18 Jan 2011
High CTC levels predicted poor outcome in metastatic breast cancer
Prof Jean-Yves Pierga - Institut Curie and Université Paris Descartes, France
High CTC levels predicted poor outcome in metastatic breast cancer ( Prof Jean-Yves Pierga - Institut Curie and Université Paris Descartes, France )
18 Jan 2011
Denosumab delayed first skeletal-related side effect
Prof Alison Stopeck - University of Arizona, Tucson, USA
Denosumab delayed first skeletal-related side effect ( Prof Alison Stopeck - University of Arizona, Tucson, USA )
18 Jan 2011
CTCs predict poor outcome from blood stem cell transplantation therapy for...
Hui Gao - MD Anderson Cancer Center, Houston, USA
CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer ( Hui Gao - MD Anderson Cancer Center, Houston, USA )
18 Jan 2011
Multidisciplinary approach to breast cancer treatment
Prof Alastair Thompson - University of Dundee, UK
Multidisciplinary approach to breast cancer treatment ( Prof Alastair Thompson - University of Dundee, UK )
11 Jan 2011
Cancer therapies that target DNA damage repair
Prof Stephen Jackson - University of Cambridge, UK
Cancer therapies that target DNA damage repair ( Prof Stephen Jackson - University of Cambridge, UK )
11 Jan 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation